CLINICAL_TRIALS
trial_result
· 2015-11-03
Clinical Trial Update: Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis [Phase 2]
Summary
Phase 2 trial update on reduced intensity hematopoietic cell transplantation for patients with resistant Langerhans cell histiocytosis has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Histiocytosis, Langerhans-cell | Phase 2 | Status: TERMINATED | Results posted: 2015-11-03